Gwangju, South Korea

Seolhwa Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Procell Therapeutics Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seolhwa Kim. Retrieved from https://idiyas.com/inventor/seolhwa-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Seolhwa Kim: Innovator in Anticancer Protein Technology**

Introduction

Seolhwa Kim, an accomplished inventor based in Gwangju, South Korea, has made significant strides in the field of cancer research. With a focus on innovative therapeutic strategies, Kim's work is distinguished by the development of technologies that address critical medical challenges related to tumor suppressors.

Latest Patents

Kim holds a notable patent titled "Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same." This invention unveils a groundbreaking approach by integrating a macromolecule transduction domain (MTD) with the tumor suppressor p18, effectively creating cell-permeable recombinant proteins. These proteins are designed to facilitate the introduction of the haploinsufficient tumor suppressor p18 into cells. This innovative method activates essential cell signaling pathways associated with ATM and p53, which are pivotal for cell cycle arrest and apoptosis in response to DNA damage or oncogenic signals. The implications of this invention extend to the design of effective anticancer agents that could revolutionize treatment methodologies.

Career Highlights

Seolhwa Kim is presently affiliated with Procell Therapeutics Inc., a company dedicated to advancing therapeutic solutions through research and innovation. His career highlights reflect an unwavering commitment to both scientific inquiry and practical applications in medicine, particularly in developing efficient oncological treatments.

Collaborations

Throughout his career, Kim has collaborated with esteemed colleagues, including Daewoong Jo and Jung-Hee Lim. These partnerships showcase his ability to work effectively within a team, combining diverse expertise to lead groundbreaking research.

Conclusion

Seolhwa Kim is an inspiring figure in the realm of biotechnology and cancer therapy. Through his patented innovations and collaborative efforts, he continues to contribute to the fight against cancer, demonstrating the critical role of inventors in transforming scientific discoveries into meaningful medical advancements. His work serves as a compelling example of how innovation can pave the way for future breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…